You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

CLINICAL TRIALS PROFILE FOR NITROPRESS


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for NITROPRESS

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00166166 ↗ Endothelial Hyperpolarization in Humans Terminated National Heart, Lung, and Blood Institute (NHLBI) Phase 2 2002-07-01 The purpose of this study is to elucidate the role Endothelium-Derived Hyperpolarizing Factor (EDHF) plays in dilating blood vessels and whether it differs between healthy people and those with high cholesterol. A second purpose of the study is to determine the identity of EDHF.
NCT00166166 ↗ Endothelial Hyperpolarization in Humans Terminated Emory University Phase 2 2002-07-01 The purpose of this study is to elucidate the role Endothelium-Derived Hyperpolarizing Factor (EDHF) plays in dilating blood vessels and whether it differs between healthy people and those with high cholesterol. A second purpose of the study is to determine the identity of EDHF.
NCT00945256 ↗ Muscle Perfusion and Protein Metabolism in Elderly Completed National Institute on Aging (NIA) Phase 1 2003-05-01 The purpose of this study was to examine the role skeletal muscle perfusion plays in mediating muscle protein synthesis in healthy older and younger individuals. The investigators hypothesized that normalization of muscle perfusion in older men and women via exercise or infusion of a vasodilator would enhance nutritive flow and skeletal muscle protein synthesis in the elderly similar to that of their younger counterparts.
NCT00945256 ↗ Muscle Perfusion and Protein Metabolism in Elderly Completed The University of Texas Medical Branch, Galveston Phase 1 2003-05-01 The purpose of this study was to examine the role skeletal muscle perfusion plays in mediating muscle protein synthesis in healthy older and younger individuals. The investigators hypothesized that normalization of muscle perfusion in older men and women via exercise or infusion of a vasodilator would enhance nutritive flow and skeletal muscle protein synthesis in the elderly similar to that of their younger counterparts.
NCT02164981 ↗ A Proof of Concept Study of Intravenous Sodium Nitroprusside in Adults With Symptomatic Schizophrenia Completed Stanley Medical Research Institute Phase 2 2015-05-01 The primary objective of this study is to investigate whether a single infusion of intravenous sodium nitroprusside (0.5 μg/kg/min for 4 hours) is superior to placebo (5% dextrose solution) at in treating positive and negative symptoms of schizophrenia
NCT02164981 ↗ A Proof of Concept Study of Intravenous Sodium Nitroprusside in Adults With Symptomatic Schizophrenia Completed Massachusetts General Hospital Phase 2 2015-05-01 The primary objective of this study is to investigate whether a single infusion of intravenous sodium nitroprusside (0.5 μg/kg/min for 4 hours) is superior to placebo (5% dextrose solution) at in treating positive and negative symptoms of schizophrenia
NCT02560805 ↗ Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV Recruiting American Heart Association Phase 2 2015-10-01 The purpose of this study is to find out why patients with post-traumatic stress disorder (PTSD) have an increased risk for heart disease and high blood pressure later in life. A second purpose is to find out what causes PTSD patients to have high adrenaline levels during stress. This study will also test if a medicine called losartan improves high adrenaline levels in patients with PTSD and if a certain gene that has to do with high blood pressure might be associated with high adrenaline levels.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for NITROPRESS

Condition Name

Condition Name for NITROPRESS
Intervention Trials
Aging 1
Hyperlipidemia 1
Schizophrenia 1
Stress Disorders, Post-Traumatic 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for NITROPRESS
Intervention Trials
Stress Disorders, Traumatic 1
Stress Disorders, Post-Traumatic 1
Schizophrenia 1
Hyperlipoproteinemias 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for NITROPRESS

Trials by Country

Trials by Country for NITROPRESS
Location Trials
United States 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for NITROPRESS
Location Trials
Georgia 2
New York 1
Massachusetts 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for NITROPRESS

Clinical Trial Phase

Clinical Trial Phase for NITROPRESS
Clinical Trial Phase Trials
Phase 2 3
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for NITROPRESS
Clinical Trial Phase Trials
Completed 2
Recruiting 1
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for NITROPRESS

Sponsor Name

Sponsor Name for NITROPRESS
Sponsor Trials
Emory University 2
National Institute on Aging (NIA) 1
The University of Texas Medical Branch, Galveston 1
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for NITROPRESS
Sponsor Trials
Other 6
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.